Imaging the limbic system in Parkinson's disease—a review of limbic pathology and clinical symptoms
M Banwinkler, H Theis, S Prange, T van Eimeren - Brain sciences, 2022 - mdpi.com
The limbic system describes a complex of brain structures central for memory, learning, as
well as goal directed and emotional behavior. In addition to pathological studies, recent …
well as goal directed and emotional behavior. In addition to pathological studies, recent …
Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies
TT Lai, B Gericke, M Feja, M Conoscenti… - npj Parkinson's …, 2023 - nature.com
Synucleinopathies are neurodegenerative disorders characterized by alpha-synuclein
(αSyn) accumulation in neurons or glial cells, including Parkinson's disease (PD), dementia …
(αSyn) accumulation in neurons or glial cells, including Parkinson's disease (PD), dementia …
A multiple hits hypothesis for memory dysfunction in Parkinson disease
S Citro, GD Lazzaro, AT Cimmino, GM Giuffrè… - Nature Reviews …, 2024 - nature.com
Cognitive disorders are increasingly recognized in Parkinson disease (PD), even in early
disease stages, and memory is one of the most affected cognitive domains. Classically …
disease stages, and memory is one of the most affected cognitive domains. Classically …
Common and distinct roles of amygdala subregional functional connectivity in non-motor symptoms of Parkinson's disease
Neuroimaging studies suggest a pivotal role of amygdala dysfunction in non-motor
symptoms (NMS) of Parkinson's disease (PD). However, the relationship between amygdala …
symptoms (NMS) of Parkinson's disease (PD). However, the relationship between amygdala …
The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety
K Chen, L Zhang, H Mao, K Chen, Y Shi… - Frontiers in Aging …, 2023 - frontiersin.org
Objective Anxiety is one of the most common psychiatric symptoms of Parkinson's disease
(PD), and brain iron deposition is considered to be one of the pathological mechanisms of …
(PD), and brain iron deposition is considered to be one of the pathological mechanisms of …
Anxiety in Parkinson's disease: A resting-state high density EEG study
N Betrouni, E Alazard, M Bayot, G Carey… - Neurophysiologie …, 2022 - Elsevier
Objective To identify markers of Parkinson's disease (PD) related anxiety, using high density
electroencephalography (hd-EEG). Methods 108 patients participated in the study. They …
electroencephalography (hd-EEG). Methods 108 patients participated in the study. They …
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: implications for early and differential diagnosis
G Menculini, E Chipi, F Paolini Paoletti… - International Journal of …, 2021 - mdpi.com
Different psychopathological manifestations, such as affective, psychotic, obsessive-
compulsive symptoms, and impulse control disturbances, may occur in most central nervous …
compulsive symptoms, and impulse control disturbances, may occur in most central nervous …
Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease
Background Parkinson's disease (PD) can present with neuropsychiatric symptoms (here,
anxiety, depression, and apathy) at any stage of the disease. We investigated the neural …
anxiety, depression, and apathy) at any stage of the disease. We investigated the neural …
[HTML][HTML] The Pathobiology of Behavioral Changes in Multiple System Atrophy: An Update
KA Jellinger - International Journal of Molecular Sciences, 2024 - ncbi.nlm.nih.gov
While cognitive impairment, which was previously considered a red flag against the clinical
diagnosis of multiple system atrophy (MSA), is a common symptom of this rare …
diagnosis of multiple system atrophy (MSA), is a common symptom of this rare …
Phenomenology of Atypical Anxiety Disorders in Parkinson's Disease: A Systematic Review
NN Dissanayaka, EJ Forbes, K Perepezko… - The American Journal of …, 2022 - Elsevier
Objective Anxiety is a prominent concern in Parkinson's disease (PD) that negatively
impacts quality of life, increases functional disability, and complicates clinical management …
impacts quality of life, increases functional disability, and complicates clinical management …